ReviewChemical & biomedical imaging2023
The Bioimaging Story of AIEgens.
Review in Chemical & biomedical imaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Aggregation-Induced Emission (AIE) Probe-Labeled Nanotheranostics: A Mini-Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
- A Caspase-3-Activatable Near-Infrared AIEgen for Tumor Apoptosis Imaging In Vivo.Chemical & biomedical imaging · 2026Article
- Harnessing Photo-Energy Conversion in Nanomaterials for Precision Theranostics.Advanced materials (Deerfield Beach, Fla.) · 2025Review
- Phosphole-Based Fluorescent Biomaterials for Imaging and Therapy.Chemical & biomedical imaging · 2025Review
- Dual-laser "808 and 1,064 nm" strategy that circumvents the Achilles' heel of photothermal therapy.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Exploring Cyclopentannulation as an Effective Synthetic Tool to Design Polycyclic Aromatic Hydrocarbon AIEgens for Bioimaging.ACS omega · 2024Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Observations of the micro world, especially the structures of organelles, have been attractive topics since the 17th century. As a powerful detection tool, the fluorescence technique has played a significant role in bioimaging to provide more details and enhance the signal-to-noise ratio compared to that of traditional optical microscopes. The boom of aggregate-induced emission luminogens (AIEgens) in the last two decades has revolutionized the design strategy of luminescent materials for biological applications. This Review summarizes the advantages and recent progress of AIEgens in imaging and tracking. Different imaging strategies of AIEgens including turn-on imaging, stimuli-response sensing, and long-term tracking are presented. NIR AIEgens used for in-depth bioimaging via different methods are also discussed. Finally, we propose several potential development directions for AIEgens in bioimaging.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.